December 5, 2020Act, analysis, analytics, business, cannabis, caucus, Congress, congressional, day, decriminalization, earl blumenauer, election, Federal, Focus Article, government, growing, house, industry, law, legal, legalization, legalize, legislation, license, marijuana, Marijuana Opportunity Reinvestment and Expungement, market, medical, medicine, MORE, of, politic, political, progress, recreational, regulation, regulations, regulatory, rep, representative, Representatives, senate, state, thc, vote, voted, voter Congress Passes MORE Act A little over a year ago, the House Judiciary Committee approved the Marijuana Opportunity Reinvestment and Expungement (MORE) Act by a 24-10 […]
September 10, 2020analysis, analytics, business, Business Analysis, cannabidiol, cannabis, cbd, compliance, Congress, congressional, controlled substances act, cultivation, dea, department of justice, derived, DOJ, Drug Enforcement Administration, farm, Farming, FDA, FDCA, Federal, food and drug administration, government, growing, hemp, industry, interim, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, National Institute of Standards and Technology, NIST, plant, plants, political, politics, product, Quality, recreational, reg, regulation, regulations, regulatory, retail, rule, safety, schedule, state, test, Testing, thc, THCA CBD Industry Caught Between Regulators & Law Enforcement The consumer-facing CBD industry operates in a regulatory gray zone even as it grows in prominence. Illegal to market as an unapproved […]